Skip to content

Effectiveness of using therapeutic ultrasound in the treatment of lower jaw joint diseases-A clinical study

Effectiveness of therapeutic ultrsound in management of chronic temporomandibular diosrders(TMDs)-A clinical trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024063
Enrollment
35
Registered
2020-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M278- Other specified diseases of jaws

Interventions

Intervention1: Therapeutic Ultrasound in temporomandibular disorder patients: The selected patients will be subjected to therapeutic ultrasound treatment (one month treatment and 3 months follow-up).T

Sponsors

Government Dental CollegeKozhikode
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with TMD as diagnosed with RDC/TMD diagnostic criteria and not responding to one month routine medical management

Exclusion criteria

Exclusion criteria: 1. Traumatic conditions , ankylosis ,neoplastic changes, developmental defects, degenerative joint diseases affecting the TMJ. 2.Patients with clicking of TMJ, but without pain or restricted mandibular movements 3. Patients with undiagnosed dental pain or who have skin lesions or facial abrasion at the site of acoustic gel placement. 4. Patients with cardiac pacemakers and cardiac arrhythmias and other uncontrolled systemic diseases. 5. Vascular disorders and neurological pain. 6. Patients with any history of seizures. 7. Pregnant and lactating mothers 8. Children less than 12 years 9.mentally disabled patients

Design outcomes

Primary

MeasureTime frame
1. Reduction in intensity of pain and masticatory muscle tenderness from the baseline to last treatment follow up visit using VAS score. 2. Improvement in mouth opening measured as a numeric variable (in mm with mean and SD).Timepoint: The primary outcome measured after one-month treatment(four sessions in four weeks of a month)

Secondary

MeasureTime frame
1.Occurrence of adverse effects will be measured using a questionnaire. 2. Recurrence of signs and symptoms in follow up period as binary variable (Yes/No). 3. Symptom-free interval as numerical variable (weeks/months).Timepoint: Measured after 3 months.

Countries

India

Contacts

Public ContactFasil VP

Government Dental College Kozhikode

abyvalsa@gmail.com9895402053

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026